1. Alzheimer's Drug Data Manipulation Exposed
Internal SEC filings and whistleblower reports have revealed that a prominent US biotech firm systematically manipulated clinical trial data for a highly touted Alzheimer's drug. Executives allegedly altered Western blot images to fabricate efficacy while suppressing negative safety signals submitted to the FDA. Despit...